Sean McClain, AbSci

'Pro­tein print­ing' Ab­Sci se­cures $125M crossover as it ex­pands syn­thet­ic bi­ol­o­gy am­bi­tions

Two months af­ter ac­quir­ing an AI en­gine it claims can po­ten­tial­ly speed up drug de­vel­op­ment by “un­prece­dent­ed” lev­els,” Ab­Sci has se­cured a hefty crossover round …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.